Functional Fas-ligand expression on T cells from HIV-1-infected patients is unrelated to CD4+ lymphopenia

International Journal of Clinical and Laboratory Research

Volumn 28, Issue 4, 1998, Pages 215-225

  Silvestris, F ^a   Cafforio, P ^a   Camarda, G ^a   Tucci, M ^a   Frassanito, M A ^a   Dammacco, F ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

AIDS; Apoptosis; CD4 lymphopenia Fas L; Th1 cells

Indexed keywords

APOPTOSIS; CELL DNA; CULTURE TECHNIQUE; CYTOFLUORIMETRY; CYTOTOXICITY; DISEASE DIAGNOSIS; DOUBLE FLUORESCENCE ANALYSIS; FAS LIGAND; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTIVITY; LYMPHOCYTOPENIA; MURINE LYMPHOMA; PROLIFERATION ASSAY; RNA SPLICING; VIRAL GENETICS;

ANTIGENS, CD95; APOPTOSIS; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; DNA PRIMERS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GENE EXPRESSION; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; INTERFERON TYPE II; LINEAR MODELS; LYMPHOPENIA; MEMBRANE GLYCOPROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE;

EID: 0032412663     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005990050048     Document Type: Article

References (68)

1. Laurent-Crawford AG, Krust B, Muller S, Rivière Y, Rey-Cuillè MA, Bechet JM, Montagnier L, Hovanessian AG. The cytopathic effect of HIV is associated with apoptosis. Virology 1991; 185:829.
2. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992; 175:331.
3. Wesselborg S, Janssen O, Kabelitz D. Induction of activation-driven death (apoptosis) in activated but not resting Peripheral blood T cells. J Immunol 1993; 150:4338.
4. Meyaard L, Otto SO, Keet IPM, Ross MT, Miedema F. Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease. J Clin Invest 1994; 93:982.
5. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Set Y, Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66:233.
6. Dhein J, Daniel PT, Trauth BC, Oehm A, Möller P, Krammer PH. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigen. J Immunol 1992; 149:3166.
7. Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E. Schooley K, Ramsdell F, Lynch DH. Fas transduces activation signals in normal human T lymphocytes. J Exp Med 1993; 178:2231.
8. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1995; 181:71.
9. Itoh N, Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 1993; 268:10932.
10. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75:1169.
11. Suda T, Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 1994; 179:873.
12. Nagata S, Golstein P. The Fas death factor. Science 1995; 267:1449.
13. Yonehara S, Nishimura Y, Kishil S, Yonehara M, Takazawa K, Tamatani T, Ishii A. Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes. Int Immunol 1995; 6:1849.
14. Glass A, Walsh CM, Lynch DH, Clark WR. Regulation of the Fas lytic pathway in cloned CTL. J Immunol 1996; 156:3638.
15. Oyaizu N, Pahwa S. Role of apoptosis in HIV disease pathogenesis. J Clin Immunol 1995; 15:217.
16. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA, Herzenberg LA. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 1995; 181:2029.
17. McCloskey TW, Oyaizu N, Klapan M, Pahwa S. Expression of the Fas antigen in patients infected with human immunodeficiency virus. Cytometry 1995; 22:111.
18. + cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Blood 1996; 87:4959.
19. Gehri R, Hahn S, Rothen M, Steuerwald M, Nuesch R, Erb P. The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells. AIDS 1996; 10:9.
20. Bäumler CB, Böhler T, Herr I, Benner A, Krammer PH, Debatin K-M. Activation of the CD95 (APO/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood 1996; 88:1741.
21. Silvestris F, Cafforio P, Frassanito MA, Tucci M, Romito A, Nagata S, Dammacco F. Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis. AIDS 1996; 10:131.
22. Westendorp MO, Frank R, Oschsenbauer C, Stricker K, Dhein J, Walczak H, Debatin K-M, Krammer PH. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995; 375:497.
23. Silvestris F, Nagata S, Cafforio P, Silvestris N, Dammacco F. The cross-linking of Fas by antibodies to a peculiar domain of gp120 V3 loop can enhance T cell apoptosis in HIV-1 infected patients. J Exp Med 1996; 184:2287.
24. Lopalco L, Desantis C, Meneveri R, Longhi E, Ginelli F, Grassi F, Siccardi AG, Beretta A. Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class I α1 peptide-binding domain. Eur J Immunol 1993; 23:2016.
25. Silvestris F, Williams RC, Dammacco F. Autoreactivity in HIV-1 infection: the role of molecular mimicry. Clin Immunol Immunopathol 1995; 75:197.
26. Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 1995; 14:1129.
27. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Misuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Naaata S. Fas ligand in human serum. Nature Med 1996; 2:317.
28. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995; 154:3806.
29. Mariani SM, Matiba B, Bäumler C, Krammer PH. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur J Immunol 1995; 25:2303.
30. Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S, Yoshino K, Okumura K, Yagita H. Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995; 182:1777.
31. Ju ST, Panka DJ, Cui H, Ettingcr R, El-Khatib M, Sherr DH, Stanger BZ. Marshak-Rothstein A. Fas(CD95)/Fas-L interactions required for programmed cell death after T-cell activation. Nature 1995; 373:444.
32. Dhein J, Walczac H, Baumler C, Debatin K-M, Krammer PH. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995; 373:438.
33. Brunner T, Mogill R, LaFace D, Yoo NJ, Mahboul A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridoma. Nature 1995; 373:441.
34. Gougeon ML, Garcia S, Heeney J, Tschoop R, Lecoeur H, Guetard V, Rame V, Dauguet C, Montagnier L. Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses 1993; 9:553.
35. + T cells from HIV-infected persons. J Immunol 1994; 153:412.
36. Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, Kupfer A. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med 1994; 2:129.
37. + T lymphocytes from HIV-infected individuals is mediated by Fas-L and tumor necrosis factor. J Exp Med 1997; 185:55.
38. Gougeon ML, Lecoeur H, Dulioust A, Enouf MG, Crouvoisier M, Goujard C, Debord T, Montagnier L. Programmed cell death in peripheral lymphocytes from HIV-infected persons. Increased susceptibility to apoptosis of CD4 and CDS T cells correlates with lymphocyte activation and with disease progression. J Immunol 1996; 156:3909.
39. Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol 1994; 6:1545.
40. + T-cell clones with different T helper phenotypes: role of CD95/CD95L interactions. Blood 1997; 82:558.
41. Center for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993; 41/RR-17:1.
42. Prussin C, Metcalfe CC. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods 1995; 188:117.
43. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139:271.
44. Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993; 151: 621.
45. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S. Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol 1994; 6:1567.
46. Herr I, Balemans L, Böhler T, Walczak H, Debatin K-M. Monitoring of CD95(APO-1/Fas) ligand expression in human T cells by quantitative RT-PCR. Cell Death Differ 1996; 3:299.
47. Reed JC Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124:1.
48. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med 1997; 3:614.
49. Strasser A, Harris AW, Huang DC, Krammer PH, Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 1995; 14:6136.
50. Huang DC, Cory S, Strasser A. Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene 1997; 14:405.
51. Pollice AA, McCoy JP, Shackney SE, Smith CA, Agarwal J, Burhoit DR. Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteins. Cytometry 1992; 13:432.
52. Takashi R, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 1994; 76:969.
53. + T lymphocytes during HIV infection. J Immunol 1996; 156:2282.
54. Muro-Chago CA, Pantaleo G, Fauci AS. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 1995; 154:5555.
55. Newell MK, Haughn LJ, Maroun CR, Julius MH. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature 1990; 347:286.
56. Radrizzani M, Accornero P, Amidei A, Aiello A, Delia D, Kurrle R, Colombo MP. IL-12 inhibits apoptosis induced in a human Th1 clone by gp120/CD4 cross-linking and CD3/TCR activation or by IL-2 deprivation. Cell Immunol 1995; 161:14.
57. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly RP, Finkel TH. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 1992; 176:1099.
58. Ricci M, Romagnani S. Reciprocal regulatory role of IFN-γand IL-4 on the in vitro development of human TH1 and TH2 clones. J Immunol 1992; 148:2142.
59. Glass A, Walsh CM, Lynch DH, Clark WR. Regulation of Fas lytic pathway in cloned CTL. J Immunol 1996; 156:3638.
60. + T-cell clones in human immunodeficiency virus infection. Blood 1994; 84: 4262.
61. + T helper type 2 and type 0 cells by T helper type 1 cells via Fas/Fas-ligand interaction. Eur J Immunol 1995; 25:2679.
62. - T cells via Fas/Fas ligand-mediated apoptosis. J Immunol 1997; 158:1503.
63. + T cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid. Immunology 1996; 87: 581.
64. Klein SA, Dobmeyer JM, Dobmeyer TS, Pape M, Ottmann OG, Helm EB, Hoelzer D, Rossol R. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 1997; 11:1111.
65. Clerici M, Sarin A, Coffman RL, Wynn TA, Blatt SP, Hendrix CW, Wolf SF, Shearer GM, Henkart PA. Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci USA 1994, 91:11811.
66. Graziosi C, Pantaleo G, Gantt KR, Fortin J-P, Demarest JF, Cohen OJ. Sékaly RP, Fauci AS. Lack of evidence for the dicotomy of Th1 and Th2 predominance in HIV infected individuals. Science 1994; 265:248.
67. Silvestris F, Camarda G, Cafforio P, Dammacco F. Upregulation of Fas ligand secretion in non-lymphopenic stages of HIV-1 infection. AIDS 1998; 12:1103.
68. Sieg S, Smith D, Yildirim Z, Kaplan D. Fas ligand deficiency in HIV disease. Proc Natl Acad Sci USA 1997; 94:5860.